109 related articles for article (PubMed ID: 4004282)
1. [Phase II study of recombinant human leukocyte A interferon on urogenital cancer patients].
Yoshimoto J; Tsushima T; Matsumura Y; Ohmori H; Saito N; Tanaka H; Asahi T; Ohkita K; Tanahashi T; Nanba K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):465-70. PubMed ID: 4004282
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy of recombinant human leukocyte A interferon (rIFN-alpha A) on malignant tumors of the urogenital tract].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):921-7. PubMed ID: 3885863
[TBL] [Abstract][Full Text] [Related]
3. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K
Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
[TBL] [Abstract][Full Text] [Related]
4. [Histopathologic evaluation of anti-tumor activity of alpha-interferon for renal cell carcinoma, especially in autoptic cases].
Yamauchi T; Kawamura J; Yoshida O; Fukuyama T; Ogura K; Nakagawa K
Hinyokika Kiyo; 1985 Sep; 31(9):1539-52. PubMed ID: 4083212
[TBL] [Abstract][Full Text] [Related]
5. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
[TBL] [Abstract][Full Text] [Related]
6. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
Kimura K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
[TBL] [Abstract][Full Text] [Related]
7. [Phase I-II study of recombinant interferon gamma].
Adachi K; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Nakada H; Tada A; Yamazaki H; Mukaiyama T
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1331-8. PubMed ID: 2988459
[TBL] [Abstract][Full Text] [Related]
8. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract][Full Text] [Related]
9. [Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors].
Niijima T; Akaza H; Koyanagi T; Togashi M; Kumamoto Y; Funyu T; Suzuki T; Orikasa S; Yoshikawa K; Koiso K
Hinyokika Kiyo; 1992 Oct; 38(10):1201-7. PubMed ID: 1481783
[TBL] [Abstract][Full Text] [Related]
10. [Phase II study of recombinant human interferon gamma (S-6810) in renal cell carcinoma. Urological Cooperative Study Group of Recombinant Human Interferon Gamma (S-6810)].
Machida T; Koiso K; Takaku F; Ogawa M
Gan To Kagaku Ryoho; 1987 Feb; 14(2):440-5. PubMed ID: 3101607
[TBL] [Abstract][Full Text] [Related]
11. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in skin malignant tumors].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):936-42. PubMed ID: 2985007
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.
Vugrin D; Hood L; Laszlo J
J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846
[TBL] [Abstract][Full Text] [Related]
13. [A case of pulmonary metastasis from renal cell carcinoma in which complete remission was achieved by interferon therapy (r-IFN-alpha A, Ro 22-8181)].
Ishito N; Wada F; Aramaki K; Asano S; Johsen T
Gan To Kagaku Ryoho; 1986 Feb; 13(2):380-3. PubMed ID: 3947113
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):913-20. PubMed ID: 3885862
[TBL] [Abstract][Full Text] [Related]
15. Phase I evaluation of a synthetic mutant of beta-interferon.
Hawkins M; Horning S; Konrad M; Anderson S; Sielaff K; Rosno S; Schiesel J; Davis T; DeMets D; Merigan T
Cancer Res; 1985 Nov; 45(11 Pt 2):5914-20. PubMed ID: 4053062
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of renal cell carcinoma. 3. Interferon therapy].
Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
[TBL] [Abstract][Full Text] [Related]
17. Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
Sarna G; Figlin R; Callaghan M
J Biol Response Mod; 1983; 2(4):343-7. PubMed ID: 6315898
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of human leukocyte interferon in patients with advanced cancer.
Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA
J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450
[TBL] [Abstract][Full Text] [Related]
19. [Recombinant interferon alpha-2 (Sch 30500) in patients with head and neck cancer].
Miyake H; Horiuchi M; Togawa K; Kawamoto K; Kaneko T; Inuyama Y; Honda Y; Baba S; Matsunaga T; Ishikawa T
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1651-5. PubMed ID: 3896156
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
Sarna G; Figlin R; McCarthy S
J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
